Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

43.56
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
37.59
Today|||52-Week Range
73.91
-19.44%
Year-to-Date
Voting Begin: Stocks Surge, Sterling Hits 2016 Highs, Futures Flirt With 2100
Jun 23 / Investing Channel - Paid Partner Content
Cancer doctors face next drug challenge
Jun 01 / FT.com - Paid Partner Content
Perrigo Sells Vitamins Business to IVC
Jun 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close43.56
Today’s openn.a.
Day’s range43.20 - 45.14
Volume2,801
Average volume (3 months)5,106,055
Market cap$22.8B
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.66%
Earnings growth (next 5 years)+11.41%
Revenue growth (last year)+21.91%
P/E ratio18.8
Price/Sales2.84
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc0.000.00%
VRTXVertex Pharmaceutica...0.000.00%
ALXNAlexion Pharmaceutic...0.000.00%
INCYIncyte Corp0.000.00%
Data as of 06/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$1.14
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Partner Offers

Search for Jobs